{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:29:40Z","timestamp":1785554980809,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.neurobiolaging.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T13:19:04Z","timestamp":1527859144000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9957-1801","authenticated-orcid":false,"given":"Nina","family":"Schultz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Byman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Wennstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","article-title":"Permeability of the blood-brain barrier to amylin","volume":"57","author":"Banks","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCRESAHA.111.258285","article-title":"Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats","volume":"110","author":"Despa","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib4","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1021\/ja3039486","article-title":"Deamidation accelerates amyloid formation and alters amylin fiber structure","volume":"134","author":"Dunkelberger","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/labinvest.3700596","article-title":"'Tissue surrogates' as a model for archival formalin-fixed paraffin-embedded tissues","volume":"87","author":"Fowler","year":"2007","journal-title":"Lab. Invest."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib6","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1038\/tp.2012.150","article-title":"Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease","volume":"3","author":"Frost","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib7","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287","author":"Fu","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002305","article-title":"Amylin deposition in the kidney of patients with diabetic nephropathy","volume":"72","author":"Gong","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer's: exploring disease in the retina","volume":"132","author":"Hart","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198608213150804","article-title":"Optic-nerve degeneration in Alzheimer's disease","volume":"315","author":"Hinton","year":"1986","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib12","first-page":"1873","article-title":"Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus","volume":"10","author":"Jeong","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib13","first-page":"226","article-title":"The blood-brain barrier and cerebral microcirculation in Alzheimer disease","volume":"4","author":"Kalaria","year":"1992","journal-title":"Cerebrovasc. Brain Metab. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2018.05.003_bib14","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in\u00a0vivo optical imaging of retinal plaques in a mouse model","volume":"54","author":"Koronyo-Hamaoui","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib15","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/01.WNL.0000033093.16450.5C","article-title":"Retinal arterial changes correlate with cerebral small-vessel disease","volume":"59","author":"Kwa","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain-from eye research to CNS disorders","volume":"9","author":"London","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ana.24992","article-title":"Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia","volume":"82","author":"Ly","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0925-4773(03)00064-9","article-title":"Abnormal blood vessel development in mice lacking presenilin-1","volume":"120","author":"Nakajima","year":"2003","journal-title":"Mech. Dev."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In\u00a0vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib20","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","article-title":"Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation","volume":"54","author":"Paulsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/41.3.8429208","article-title":"A\u00a0method for exposing hidden antigenic sites in paraformaldehyde-fixed cultured cells, applied to initially unreactive antibodies","volume":"41","author":"Peranen","year":"1993","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JAD-140210","article-title":"Positive association between plasma amylin and cognition in a homebound elderly population","volume":"42","author":"Qiu","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/eye.2015.100","article-title":"Dementia of the eye: the role of amyloid beta in retinal degeneration","volume":"29","author":"Ratnayaka","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib24","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1177\/0271678X16657093","article-title":"Amylin alters human brain pericyte viability and NG2 expression","volume":"37","author":"Schultz","year":"2016","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib27","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1096\/fj.201700431R","article-title":"Amyloid-beta and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model","volume":"31","author":"Wijesekara","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2018.05.003_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease","volume":"20","author":"Zhu","year":"2014","journal-title":"Mol. Psychiatry"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018301593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018301593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T23:48:13Z","timestamp":1560383293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458018301593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"alternative-id":["S0197458018301593"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.05.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}